1. Home
  2. SONM vs APLM Comparison

SONM vs APLM Comparison

Compare SONM & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • APLM
  • Stock Information
  • Founded
  • SONM 1999
  • APLM 2016
  • Country
  • SONM United States
  • APLM United States
  • Employees
  • SONM N/A
  • APLM N/A
  • Industry
  • SONM Telecommunications Equipment
  • APLM Blank Checks
  • Sector
  • SONM Telecommunications
  • APLM Finance
  • Exchange
  • SONM Nasdaq
  • APLM Nasdaq
  • Market Cap
  • SONM 15.0M
  • APLM 15.6M
  • IPO Year
  • SONM 2019
  • APLM N/A
  • Fundamental
  • Price
  • SONM $2.83
  • APLM $0.16
  • Analyst Decision
  • SONM
  • APLM Strong Buy
  • Analyst Count
  • SONM 0
  • APLM 2
  • Target Price
  • SONM N/A
  • APLM $4.25
  • AVG Volume (30 Days)
  • SONM 19.4K
  • APLM 934.3K
  • Earning Date
  • SONM 11-12-2024
  • APLM 08-14-2024
  • Dividend Yield
  • SONM N/A
  • APLM N/A
  • EPS Growth
  • SONM N/A
  • APLM N/A
  • EPS
  • SONM N/A
  • APLM N/A
  • Revenue
  • SONM $69,288,000.00
  • APLM $2,101,000.00
  • Revenue This Year
  • SONM N/A
  • APLM N/A
  • Revenue Next Year
  • SONM $107.78
  • APLM N/A
  • P/E Ratio
  • SONM N/A
  • APLM N/A
  • Revenue Growth
  • SONM N/A
  • APLM 70.54
  • 52 Week Low
  • SONM $2.32
  • APLM $0.11
  • 52 Week High
  • SONM $10.70
  • APLM $3.18
  • Technical
  • Relative Strength Index (RSI)
  • SONM 50.12
  • APLM 60.35
  • Support Level
  • SONM $2.67
  • APLM $0.13
  • Resistance Level
  • SONM $3.11
  • APLM $0.18
  • Average True Range (ATR)
  • SONM 0.27
  • APLM 0.01
  • MACD
  • SONM 0.04
  • APLM 0.00
  • Stochastic Oscillator
  • SONM 27.17
  • APLM 65.52

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the United States, and to Bell, Rogers, and Telus Mobility in Canada. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About APLM Apollomics Inc.

Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

Share on Social Networks: